EVOLUTION
Est. 2014

Coast-to-Coast
Life Science
Expertise

Bridging Wall Street financial acumen with West Coast biotech innovation. Dedicated investment banking for the C-suite.

The ELSP Difference

We fill a critical need for unbiased, independent advice in the life sciences sector.

Experienced Professionals

Senior bankers with strong track records and over 100 transactions as a group.

Strategic Consultative Approach

In-depth due diligence process before recommending any course of action.

Cross Border Expertise

Worldwide pharmaceutical and biotech contacts to provide expert M&A assistance.

Independent & Objective

No conflicts with capital markets, research analysts or investment funds.

Our Expertise

Comprehensive Advisory

01

Strategic Transaction Initiation

  • Licensing & Partnering
  • Mergers & Acquisitions
  • Fairness Opinions
02

Capital Markets Services

  • Equity & Debt Financings
  • Valuations
  • Non-deal Investor Meetings
03

Pre-Transaction Advisory

  • Valuation Roadmap
  • Inflection Point Analysis
  • Success Maximization

Senior Leadership

Our team has worked together for over 15 years, previously serving in a life sciences venture capital fund.

N

Neal Fischer

Managing Director

M

Mary Tanner

Senior Managing Director

A

Anton Gueth

Managing Director

C

Christa Nicholas

Director

D

David Parke

Managing Director

I

Ileine Sanchez

Scientific Advisor

Relevant Experience & Qualifications

antares
epiontis
evotec
HARVARD
JOHNS HOPKINS
Yale University
SF Biotech Hub
Philadelphia Skyline
NY Wall Street

Partner with Evolution

Maximize your selling thesis with a partner that understands the unique aspects of every situation.